Total Payments
$545,773
2024 Payments
$598.32
Companies
29
Transactions
559
Medicare Patients
898
Medicare Billing
$91,254
Payment Breakdown by Category
Other$399,769 (73.2%)
Travel$82,553 (15.1%)
Consulting$47,635 (8.7%)
Food & Beverage$15,212 (2.8%)
Research$604.33 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $388,169 | 119 | 71.1% |
| Travel and Lodging | $82,553 | 185 | 15.1% |
| Consulting Fee | $47,635 | 14 | 8.7% |
| Food and Beverage | $15,212 | 234 | 2.8% |
| Honoraria | $11,600 | 4 | 2.1% |
| Unspecified | $604.33 | 3 | 0.1% |
Payments by Type
General
$545,168
556 transactions
Research
$604.33
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $230,205 | 222 | $0 (2021) |
| PFIZER INC. | $123,742 | 116 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $91,979 | 72 | $0 (2019) |
| Janssen Biotech, Inc. | $57,679 | 60 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $22,306 | 21 | $0 (2019) |
| Blue Earth Diagnostics Limited | $11,156 | 12 | $0 (2019) |
| Astellas Pharma Global Development | $3,694 | 5 | $0 (2023) |
| Intuitive Surgical, Inc. | $1,358 | 6 | $0 (2019) |
| AngioDynamics, Inc. | $1,215 | 3 | $0 (2023) |
| Boston Scientific Corporation | $667.24 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $598.32 | 9 | PROCEPT BioRobotics Corporation ($259.31) |
| 2023 | $3,496 | 7 | Astellas Pharma Global Development ($2,060) |
| 2022 | $304.33 | 3 | Astellas Pharma Global Development ($234.50) |
| 2021 | $15,498 | 11 | PFIZER INC. ($11,600) |
| 2020 | $67,890 | 68 | PFIZER INC. ($44,148) |
| 2019 | $128,359 | 130 | Astellas Pharma US Inc ($40,113) |
| 2018 | $225,097 | 211 | Janssen Scientific Affairs, LLC ($87,784) |
| 2017 | $104,530 | 120 | Astellas Pharma US Inc ($82,562) |
All Payment Transactions
559 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $31.49 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $60.51 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $23.10 | General |
| Category: Urology | ||||||
| 11/01/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $110.20 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/16/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $40.83 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: UROLOGY | ||||||
| 04/30/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $102.83 | General |
| Category: UROLOGY | ||||||
| 02/13/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $89.66 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2023 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $79.15 | General |
| Category: LithoVue_URO | ||||||
| 07/11/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $77.93 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $63.86 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $375.37 | General |
| Category: OS | ||||||
| 01/17/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $685.30 | General |
| Category: OS | ||||||
| 01/04/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Travel and Lodging | In-kind items and services | $153.89 | General |
| Category: OS | ||||||
| 01/01/2023 | Astellas Pharma Global Development | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $2,060.00 | General |
| Category: Oncology | ||||||
| 06/15/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $46.63 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 03/07/2022 | UroGen Pharma, Inc. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: UROTHELIAL CANCER | ||||||
| 02/28/2022 | Astellas Pharma Global Development | Xtandi (Drug) | — | In-kind items and services | $234.50 | Research |
| Study: A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT) • Category: Oncology | ||||||
| 10/08/2021 | PFIZER INC. | XTANDI (Drug) | Honoraria | Cash or cash equivalent | $4,000.00 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2021 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| 10/01/2021 | PFIZER INC. | ORGOVYX (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 08/31/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Consulting Fee | Cash or cash equivalent | $3,217.50 | General |
| Category: ONCOLOGY | ||||||
| 04/20/2021 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $91.37 | General |
| Category: Wound Closure | ||||||
| 04/14/2021 | Olympus America Inc. | Dornier MedTech | Food and Beverage | In-kind items and services | $111.47 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT) | Astellas Pharma Global Development | $604.33 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 229 | 285 | $98,602 | $25,156 |
| 2022 | 6 | 286 | 359 | $110,476 | $28,951 |
| 2021 | 7 | 263 | 320 | $101,202 | $28,712 |
| 2020 | 4 | 120 | 128 | $37,271 | $8,434 |
Total Patients
898
Total Services
1,092
Medicare Billing
$91,254
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 33 | 42 | $30,114 | $7,373 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 109 | $25,070 | $6,954 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 44 | $14,960 | $4,374 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $18,725 | $4,028 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $9,369 | $2,332 | 24.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 27 | 28 | $364.00 | $95.48 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 144 | $33,120 | $9,588 | 29.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 34 | 40 | $28,680 | $7,737 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $19,795 | $4,230 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 43 | $14,620 | $4,069 | 27.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $13,533 | $3,134 | 23.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 48 | 56 | $728.00 | $192.87 | 26.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 100 | $23,000 | $7,480 | 32.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $28,890 | $7,400 | 25.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 22 | 24 | $17,208 | $4,960 | 28.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $10,608 | $3,095 | 29.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 34 | 34 | $11,798 | $2,785 | 23.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 26 | $8,840 | $2,764 | 31.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 51 | 66 | $858.00 | $229.68 | 26.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $14,980 | $3,907 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 21 | 24 | $5,428 | $1,501 | 27.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 15 | 15 | $5,110 | $1,332 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 32 | 35 | $4,691 | $961.07 | 20.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 11 | 11 | $6,867 | $680.78 | 9.9% |
| 81002 | Urinalysis, manual test | Office | 2020 | 13 | 15 | $195.00 | $52.20 | 26.8% |
About Dr. Jonathan Silberstein, M.D
Dr. Jonathan Silberstein, M.D is a Urology healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063568491.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Silberstein, M.D has received a total of $545,773 in payments from pharmaceutical and medical device companies, with $598.32 received in 2024. These payments were reported across 559 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($388,169).
As a Medicare-enrolled provider, Silberstein has provided services to 898 Medicare beneficiaries, totaling 1,092 services with total Medicare billing of $91,254. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Aventura, FL
- Active Since 01/26/2007
- Last Updated 10/15/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1063568491
Products in Payments
- XTANDI (Drug) $216,285
- Erleada (Drug) $158,366
- Xtandi (Drug) $51,662
- SUTENT (Drug) $12,051
- Axumin (Drug) $11,156
- ERLEADA (Drug) $6,099
- ORGOVYX (Drug) $2,500
- Da Vinci Surgical System (Device) $1,358
- NANOKNIFE (Device) $1,215
- LITHOVUE (Device) $351.22
- AQUABEAM SYSTEM (Device) $259.31
- PROLARIS (Device) $228.10
- UROLIFT (Device) $151.03
- PENILE RECONSTRUCTION (Device) $134.74
- OFIRMEV (Drug) $125.00
- AMS (Device) $123.92
- REZUM (Device) $112.95
- MYRBETRIQ (Drug) $104.48
- STRATAFIX (Device) $91.37
- LithoVue (Device) $79.15
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Aventura
Boris Klopukh, Md, MD
Urology — Payments: $7,464
Urology $7,464
Floyd Seskin, Md, MD
Urology — Payments: $7,077
Urology $7,077
Jay Kim, Md, MD
Urology — Payments: $6,961
Urology $6,961
Giridhar Talluri, Md, MD
Urology — Payments: $4,850
Urology $4,850
Mark Weitzenfeld, Md, MD
Urology — Payments: $4,250
Urology $4,250
Dr. Richard Levin, Md, MD
Urology — Payments: $3,092
Urology $3,092